A detailed history of Engineers Gate Manager LP transactions in Hille Vax, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 13,835 shares of HLVX stock, worth $23,796. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,835
Previous 37,398 63.01%
Holding current value
$23,796
Previous $65,000 56.92%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$1.72 - $2.06 $40,528 - $48,539
-23,563 Reduced 63.01%
13,835 $28,000
Q3 2024

Nov 14, 2024

BUY
$1.58 - $14.42 $59,088 - $539,279
37,398 New
37,398 $65,000

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $57.5M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.